Canadian application, no grantCanada
Toso as a target for drug screening
CA 2326219 A1 · Owner: Rigel Pharmaceuticals, Inc. · Inventors: Payan, Donald
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to methods for identifying novel compositions which modulate the activity of Toso and the use of such , compositions in diagnosis and treatment of disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 30, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 30, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 30, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 30, 1999
GrantedNo grant recorded
Term endedMarch 30, 2019
Patent numberCA 2326219 A1
Classification (IPC)C12Q1/68 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.